doi: 10.1093/jnci/djj111.
China approves world's first oncolytic virus therapy for cancer treatment
- PMID: 16507823
- DOI: 10.1093/jnci/djj111
Item in Clipboard
China approves world's first oncolytic virus therapy for cancer treatment
J Natl Cancer Inst.
.
No abstract available
Similar articles
-
Cancer gene therapy with oncolytic adenoviruses.J BUON. 2009 Sep;14 Suppl 1:S7-15. J BUON. 2009. PMID: 19785073 Review.
-
Potentiation of oncolytic virotherapy with armed shRNA.Cancer Biol Ther. 2009 Jan;8(1):92-3. doi: 10.4161/cbt.8.1.7422. Epub 2009 Jan 14. Cancer Biol Ther. 2009. PMID: 19127117 No abstract available.
-
The end of the beginning: oncolytic virotherapy achieves clinical proof-of-concept.Mol Ther. 2006 Feb;13(2):237-8. doi: 10.1016/j.ymthe.2005.12.005. Epub 2005 Dec 20. Mol Ther. 2006. PMID: 16376156 No abstract available.
-
[Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].Mol Biol (Mosk). 2012 Jul-Aug;46(4):556-69. Mol Biol (Mosk). 2012. PMID: 23113343 Review. Russian.
-
Oncolytic viruses and histone deacetylase inhibitors--a multi-pronged strategy to target tumor cells.Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):153-9. doi: 10.1016/j.cytogfr.2010.03.002. Epub 2010 Apr 14. Cytokine Growth Factor Rev. 2010. PMID: 20395162 Review.
Cited by
-
Therapeutic Implementation of Oncolytic Viruses for Cancer Immunotherapy: Review of Challenges and Current Clinical Trials.J Biomed Sci Res. 2022;4(2):164. doi: 10.36266/JBSR/164. Epub 2022 Oct 20. J Biomed Sci Res. 2022. PMID: 36381110 Free PMC article.
-
The limiting factors of oncolytic virus immunotherapy and the approaches to overcome them.Appl Microbiol Biotechnol. 2020 Oct;104(19):8231-8242. doi: 10.1007/s00253-020-10802-w. Epub 2020 Aug 20. Appl Microbiol Biotechnol. 2020. PMID: 32816087 Review.
-
The influence of innate and pre-existing immunity on adenovirus therapy.J Cell Biochem. 2009 Nov 1;108(4):778-90. doi: 10.1002/jcb.22328. J Cell Biochem. 2009. PMID: 19711370 Free PMC article. Review.
-
Oncolytic virus and PD-1/PD-L1 blockade combination therapy.Oncolytic Virother. 2018 Jul 31;7:65-77. doi: 10.2147/OV.S145532. eCollection 2018. Oncolytic Virother. 2018. PMID: 30105219 Free PMC article. Review.
-
AAV's anatomy: roadmap for optimizing vectors for translational success.Curr Gene Ther. 2010 Oct;10(5):319-340. doi: 10.2174/156652310793180706. Curr Gene Ther. 2010. PMID: 20712583 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
